The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Destabilization of Fatty Acid Synthase by Acetylation Inhibits De Novo Lipogenesis and Tumor Cell Growth
Open accessPublished version of a preprint
Abstract
Fatty acid synthase (FASN) is the terminal enzyme in de novo lipogenesis and plays a key role in cell proliferation. Pharmacologic inhibitors of FASN are being evaluated in clinical trials for treatment of cancer, obesity, and other diseases. Here, we report a previously unknown mechanism of FASN regulation involving its acetylation by KAT8 and its deacetylation by HDAC3. FASN acetylation promoted its degradation via the ubiquitin–proteasome pathway. FASN acetylation enhanced its association with the E3 ubiquitin ligase TRIM21. Acetylation destabilized FASN and resulted in decreased de novo lipogenesis and tumor cell growth. FASN acetylation was frequently reduced in human hepatocellular carcinoma samples, which correlated with increased HDAC3 expression and FASN protein levels. Our results suggest opportunities to target FASN acetylation as an anticancer strategy. Cancer Res; 76(23); 6924–36. ©2016 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“GNPATK128Ac also displayed an increased ability to bind fatty acid synthase FASN (which has also been found to be a target of acetylation-mediated protein homeostasis [59]), an enzyme central to lipogenesis and commonly dysregulated in cancer.”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [59]
The cited source says what the claim attributes to it.
In the citing paper
“The GNPATK128Ac-FASN interaction resulted in a repression of TRIM21-mediated FASN degradation [59] and a subsequent increase in FASN, triglyceride, and fatty acids levels consistent with an increase in lipogenesis (Figure 2B).”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Lysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
Regulation of cellular metabolism by protein lysine acetylation
Zhao, S., Xu, W., Jiang, W., Yu, W., Lin, Y., Zhang, T., Yao, J., Zhou, L., Zeng, Y., Li, H., et al. (2010) · Science · doi:10.1126/science.1179689 · Cited by 1,910
Self-citationThe growing landscape of lysine acetylation links metabolism and cell signalling
Choudhary, C., Weinert, B. T., Nishida, Y., Verdin, E., & Mann, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3841 · Cited by 1,324
Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology
Kuhajda, F. P. (2000) · Nutrition · doi:10.1016/s0899-9007(99)00266-x · Cited by 801
Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity
Kridel, S. J., Axelrod, F. T., Rozenkrantz, N., & Smith, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3645 · Cited by 610
Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases
Lahm, A., Paolini, C., Pallaoro, M., Nardi, M. C., Jones, P., Neddermann, P., Sambucini, S., Bottomley, M. J., Lo Surdo, P., Carfı́, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706487104 · Cited by 566
Lundby, A., Lage, K., Weinert, B. T., Bekker‐Jensen, D. B., Secher, A., Skovgaard, T., Kelstrup, C. D., Dmytriyev, A., Choudhary, C., Lundby, C., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.07.006 · Cited by 563
Fatty Acid Synthase As a Potential Therapeutic Target in Cancer
Flavin, R., Peluso, S., Nguyen, P. L., & Loda, M. F. (2010) · Future Oncology · doi:10.2217/fon.10.11 · Cited by 545
Cited by
Sorted by citations
Bian, X., Liu, R. R., Meng, Y., Xing, D., Xu, D., & Lu, Z. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20201606 · Cited by 1,037
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
Butler, L. M., Perone, Y., Dehairs, J., Lupien, L. E., de Laat, V., Talebi, A., Loda, M., Kinlaw, W. B., & Swinnen, J. V. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.013 · Cited by 589
Zhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442
Fatty Acid Synthase: An Emerging Target in Cancer
Fhu, C. W., & Ali, A. (2020) · Molecules · doi:10.3390/molecules25173935 · Cited by 402
Li, W., Li, F., Zhang, X., Lin, H., & Xu, C. S. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00825-8 · Cited by 211
Self-citationLipid Metabolic Reprogramming in Hepatocellular Carcinoma
Nakagawa, H., Hayata, Y., Kawamura, S., Yamada, T., Fujiwara, N., & Koike, K. (2018) · Cancers · doi:10.3390/cancers10110447 · Cited by 176
Gu, L., Zhu, Y., Lin, X., Tan, X., Lu, B., & Li, Y. (2020) · Oncogene · doi:10.1038/s41388-020-1156-0 · Cited by 156
Liu, B., Jiang, S., Li, M., Xiong, X., Zhu, M., Li, D., Zhao, L., Qian, L., Zhai, L., Li, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07185-y · Cited by 164
Neddylation of PTEN regulates its nuclear import and promotes tumor development
Xie, P., Peng, Z., Chen, Y., Li, H., Du, M., Tan, Y., Zhang, X., Lü, Z., Cui, C., Liu, C. H., et al. (2020) · Cell Research · doi:10.1038/s41422-020-00443-z · Cited by 166
Gastric cancer: Metabolic and metabolomics perspectives (Review)
Xiao, S., & Zhou, L. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4000 · Cited by 160
Self-citationLipid Metabolism in Development and Progression of Hepatocellular Carcinoma
Sangineto, M., Villani, R., Cavallone, F., Romano, A. D., Loizzi, D., & Serviddio, G. (2020) · Cancers · doi:10.3390/cancers12061419 · Cited by 153
Protein post-translational modifications in the regulation of cancer hallmarks
Wang, H., Yang, L., Liu, M., & Luo, J. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00464-3 · Cited by 148
Wu, Y., Zhou, L., Zou, Y., Zhang, Y., Zhang, M., Xu, L., Zheng, L., He, W., Yu, K., Li, T., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00522-1 · Cited by 134
Self-citationFBXW7β loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth
Wei, W., Qin, B., Wen, W., Zhang, B., Luo, H., Wang, Y., Xu, H., Xie, X., Liu, S., Jiang, X. J., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01405-8 · Cited by 119
Hu, Y., He, W., Huang, Y., Xiang, H., Guo, J., Che, Y., Cheng, X., Hu, F., Hu, M., Ma, T., et al. (2021) · Hepatology · doi:10.1002/hep.32045 · Cited by 105
Loo, S. Y., Toh, L. P., Xie, W. H., Pathak, E., Tan, W. W. S., Ma, S., Lee, M. Y., Shatishwaran, S., Yeo, J. Z. Z., Yuan, J. X., et al. (2021) · Science Advances · doi:10.1126/sciadv.abh2443 · Cited by 94
Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses
Foglia, B., Beltrà, M., Sutti, S., & Cannito, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087463 · Cited by 82
Bovo, S., Mazzoni, G., Bertolini, F., Schiavo, G., Galimberti, G., Gallo, M., Dall’Olio, S., & Fontanesi, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-43297-1 · Cited by 78
Gong, Z., Zhu, J., Chen, J., Feng, F., Zhang, H., Zhang, Z., Song, C., Liang, K., Yang, S., Fan, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40975-7 · Cited by 72
Fatty acid synthesis suppresses dietary polyunsaturated fatty acid use
Worthmann, A., Ridder, J., Piel, S., Evangelakos, I., Musfeldt, M., Voß, H., O’Farrell, M., Fischer, A. W., Adak, S., Sundd, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44364-y · Cited by 69
Xiong, L., Ye, X., Chen, Z., Fu, H., Li, S., Xu, P. A., Yu, J., Wen, L., Gao, R., Fu, Y., et al. (2021) · Aging Cell · doi:10.1111/acel.13491 · Cited by 67
Amiar, S., Katris, N. J., Berry, L., Dass, S., Duley, S., Arnold, C.-S., Shears, M. J., Brunet, C. D., Touquet, B., McFadden, G. I., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.072 · Cited by 70
Oxidative Stress and Reprogramming of Lipid Metabolism in Cancers
Li, S., Yuan, H., Li, L., Li, Q., Lin, P., & Li, K. (2025) · Antioxidants · doi:10.3390/antiox14020201 · Cited by 75
The Genetic Basis of Childhood Obesity: A Systematic Review
Vourdoumpa, A., Paltoglou, G., & Charmandari, E. (2023) · Nutrients · doi:10.3390/nu15061416 · Cited by 84
Gutiérrez‐Cuevas, J., Lucano‐Landeros, S., López-Cifuentes, D., Santos, A., & Armendáriz‐Borunda, J. (2022) · Cancers · doi:10.3390/cancers15010023 · Cited by 64
Yamamoto, T., Hayashida, T., Masugi, Y., Oshikawa, K., Hayakawa, N., Itoh, M., Nishime, C., Suzuki, M., Nagayama, A., Kawai, Y., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-2266 · Cited by 60
Zhao, Z., Wang, Y., Yun, D., Huang, Q., Meng, D., Li, Q., Zhang, P., Wang, C., Chen, H., & Lu, D. (2020) · PubMed Central · Cited by 58
Targeting Chemoresistant Tumors: Could TRIM Proteins-p53 Axis Be a Possible Answer?
Valletti, A., Marzano, F., Pesole, G., Sbisà, E., & Tullo, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071776 · Cited by 55
Chen, X., Huang, W., Zhang, J., Li, Y., Xing, Z., Guo, L., Jiang, H., & Zhang, J. (2023) · BMC Biology · doi:10.1186/s12915-023-01698-9 · Cited by 50
Targeting Dysregulated Lipid Metabolism in Cancer with Pharmacological Inhibitors
Gupta, A., Das, D., & Taneja, R. (2024) · Cancers · doi:10.3390/cancers16071313 · Cited by 52
Metabolic reprogramming in type 2 diabetes and the development of breast cancer
Martin, S. D., & McGee, S. L. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0037 · Cited by 47
Targeting ZDHHC21/FASN axis for the treatment of diffuse large B-cell lymphoma
Liu, B., Zhao, X., Zhang, S., Li, Q., Li, X., Huang, D., Xia, J., Ma, N., Duan, Y., Zhang, X., et al. (2024) · Leukemia · doi:10.1038/s41375-023-02130-5 · Cited by 46
TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability
Chen, X., Yong, H., Chen, M., Deng, C., Wang, P., Chu, S., Li, M., Hou, P., Zheng, J., Li, Z., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02583-z · Cited by 44
Tian, M., Hao, F., Jin, X., Sun, X. J., Jiang, Y., Wang, Y., Li, D., Chang, T., Zou, Y., Peng, P., et al. (2021) · eLife · doi:10.7554/elife.62394 · Cited by 41
Self-citationIntrauterine Inflammation Alters the Transcriptome and Metabolome in Placenta
Lien, Y., Zhang, Z., Barila, G., Brown, A. G., Elovitz, M. A., & Simmons, R. A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.592689 · Cited by 44
COX17 acetylation via MOF–KANSL complex promotes mitochondrial integrity and function
Guhathakurta, S., Erdogdu, N. U., Hoffmann, J. J., Grządzielewska, I., Schendzielorz, A. B., Seyfferth, J., Mårtensson, C. U., Corrado, M., Karoutas, A., Warscheid, B., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00904-w · Cited by 39
Zhang, B., Zhou, B., Xiao, M., Li, H., Guo, L., Wang, M.-X., Yu, S., & Ye, Q. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01025 · Cited by 38
Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy
Li, X.-M., Zhao, Z., Xiao, Y., Xia, Q., Zhou, P., Wang, S., Wu, H., & Hu, J. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00394-2 · Cited by 40
Ouyang, Q., Lin, X., Zhu, Y., Zheng, B. J., Liang, L., Yang, Y., Hou, G., Chen, X., Luo, G., Huo, F., et al. (2017) · Hepatology · doi:10.1002/hep.29562 · Cited by 36
Fatty acid synthase: a druggable driver of breast cancer brain metastasis
Menéndez, J. A., & Lupu, R. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2077189 · Cited by 37
Huang, W., Su, J., Chen, X., Li, Y., Xing, Z., Guo, L., Li, S., & Zhang, J. (2023) · Metabolites · doi:10.3390/metabo13050647 · Cited by 39
Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma
Mohanty, A. R., Sandoval, N., Phan, A. T., Nguyen, T. V., Chen, R. W., Budde, L. E., Mei, M. G., Popplewell, L. L., Pham, L. V., Kwak, L. W., et al. (2018) · Blood · doi:10.1182/blood-2018-05-851667 · Cited by 40
CSN6–TRIM21 axis instigates cancer stemness during tumorigenesis
Qin, B., Zou, S., Li, K., Wang, H., Wei, W., Zhang, B., Xiao, L., Choi, H. H., Tang, Q., Huang, D., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0779-9 · Cited by 36
Posttranslational control of lipogenesis in the tumor microenvironment
Zhu, Y., Lin, X., Zhou, X., Prochownik, E. V., Wang, X., & Li, Y. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01340-1 · Cited by 39
C/EBPδ-Slug-Lox1 axis promotes metastasis of lung adenocarcinoma via oxLDL uptake
Wang, D., Cheng, X., Li, Y., Guo, M., Zhao, W., Qiu, J., Zheng, Y. F., Meng, M., Ping, X., Chen, X., et al. (2019) · Oncogene · doi:10.1038/s41388-019-1015-z · Cited by 34
The Ubiquitin–Proteasome System in Tumor Metabolism
Wang, J., Xiang, Y., Fan, M., Fang, S., & Hua, Q. (2023) · Cancers · doi:10.3390/cancers15082385 · Cited by 32
Genes in human obesity loci are causal obesity genes in C. elegans
Ke, W., Reed, J. N., Yang, C., Higgason, N. M., Rayyan, L., Wählby, C., Carpenter, A. E., Civelek, M., & O’Rourke, E. J. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009736 · Cited by 32
Fatty acid synthase ( FASN ) signalome: A molecular guide for precision oncology
Menéndez, J. A., Cuyàs, E., Encinar, J. A., Steen, T. V., Verdura, S., Llop‐Hernández, À., López, J., Serrano‐Hervás, E., Osuna, S., Martín-Castillo, B., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13582 · Cited by 41
The role of acetylation and deacetylation in cancer metabolism
Wang, C., & Ma, X. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70145 · Cited by 32
You, B., Hour, M., Chen, L., Luo, S.-C., Hsu, P.-H., & Lee, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-39778-y · Cited by 30
Li, A., Wang, R., Zhao, Y. Q., Zhao, P., & Yang, J. (2024) · Metabolites · doi:10.3390/metabo14060325 · Cited by 29
Zhou, R., Yang, Y., Park, S., Seo, Y.-W., Jung, S.-C., Kim, K. K., Kim, K., & Kim, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-40238-w · Cited by 27
Miao, T., Kim, J., Kang, P., Fujiwara, H., Hsu, F., & Bai, H. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2212220119 · Cited by 29
Tian, Y., Ma, J., Wang, H., Yi, X., Wang, H., Zhang, H., Guo, S., Yang, Y., Zhang, B., Du, J., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04965-8 · Cited by 26
Qiu, B., Li, S., Li, M., Wang, S., Mu, G., Chen, K., Wang, M., Zhu, W., Wang, W., Wang, J., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05582-w · Cited by 26
Zhao, Q., Zhang, Z., Li, J., Xu, F., Zhang, B., Liu, M., Liu, Y., Chen, H., Yang, J., & Zhang, J. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.572663 · Cited by 25
Wei, S., Liu, W., Sun, N., Wu, Y., Song, H., Wang, C., Wang, S., Zou, R., Lin, L., Zeng, K., et al. (2021) · Cancer Science · doi:10.1111/cas.14836 · Cited by 25
Self-citationNikolaou, K. C., Godbersen, S., Manoharan, M., Wieland, S. F., Heim, M. H., & Stoffel, M. (2023) · JCI Insight · doi:10.1172/jci.insight.164694 · Cited by 24
Roles of posttranslational modifications in lipid metabolism and cancer progression
Feng, T., Zhang, H., Zhou, Y., Zhu, Y., Shi, S., Li, K., Lin, P., & Chen, J. (2024) · Biomarker Research · doi:10.1186/s40364-024-00681-y · Cited by 23
The histone acetyltransferase Mof regulates Runx2 and Osterix for osteoblast differentiation
Chen, J., Liu, D., Chen, B., Yang, Y., Zhu, H., Li, D., Liu, K., Zhu, L., Liu, H., Li, M., et al. (2023) · Cell and Tissue Research · doi:10.1007/s00441-023-03791-5 · Cited by 23
Zhang, K., Yang, C. C., Zhou, X. M., Liang, J. H., Guo, J., Li, M., Zhang, Y., Shao, S., Sun, P. G., Li, K., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04820-w · Cited by 23
Jiang, X., Wu, Y., Zhong, H., Zhang, X., Sun, X., Liu, L., Cui, X., Chi, X., & Ji, C. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08206-2 · Cited by 23
ROSS, K. E., Zhang, G., Akçora, C. G., Lin, Y., Fang, B., Koomen, J. M., Haura, E. B., & Grimes, M. L. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010690 · Cited by 21
Acetylation: a new target for protein degradation in cancer
Crawford, C. E. W., & Burslem, G. M. (2025) · Trends in Cancer · doi:10.1016/j.trecan.2025.01.013 · Cited by 20
Hsu, C.-H., & Yu, Y. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03143-x · Cited by 20
Xu, J., Guan, X., Jia, X., Li, H., Chen, R., & Lu, Y. (2022) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2022.100255 · Cited by 19
Omeprazole, an inhibitor of proton pump, suppresses De novo lipogenesis in gastric epithelial cells
Chen, P., Li, L., Wang, H., Zhao, J., Cheng, Y., Xie, J., Cao, M., Huang, L., Yang, F., Chen, H., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110472 · Cited by 20
Ishikawa, C., Barreyro, L., Sampson, A. M., Hueneman, K. M., Choi, K., Philbrook, S. Y., Choi, I., Bolanos, L. C., Wunderlich, M., Volk, A. G., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci184665 · Cited by 17
Xu, X., Li, H., Lin, H., Li, Q., Liu, Y., Huang, W., Yang, J., Li, N., Gao, Z., Wang, S., et al. (2026) · Hepatology · doi:10.1097/hep.0000000000001429 · Cited by 16
Self-citationProtein acetylation: a novel modus of obesity regulation
Liu, Y., Yang, H., Liu, X., Gu, H., Li, Y., & Sun, C. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02082-2 · Cited by 15
Martín-Bernabé, A., Balcells, C. D., Tarragó‐Celada, J., Foguet, C., Bourgoin‐Voillard, S., Seve, M., & Cascante, M. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.05.011 · Cited by 15
Basavaraj, P., Ruangsai, P., Hsieh, P., Jiang, W., BAU, D.-T., Huang, G., & Huang, W. (2022) · Life · doi:10.3390/life12111769 · Cited by 15
Yang, H., Liu, Y., Liu, X., Gu, H., Zhang, J., & Sun, C. (2020) · Stem Cells International · doi:10.1155/2020/7618506 · Cited by 13
Genetic overlap between Alzheimer's disease and blood lipid levels
van der Linden, R. J., Reus, L. M., Witte, W. D., Tijms, B. M., Rikkert, M. G. M. O., Visser, P. J., & Poelmans, G. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.06.019 · Cited by 13
Wong, T. L., Kong, Y., & Ma, S. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000837 · Cited by 15
Regulation of lipid metabolism by E3 ubiquitin ligases in lipid-associated metabolic diseases
Zou, Y., Zhang, Y., Li, M., Cao, K., Song, C., Zhang, Z., Cai, K., Geng, D., Chen, S., Wu, Y., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.130961 · Cited by 13
Aghayev, M., Arias-Alvarado, A., Ilchenko, S., Lepp, J., Scott, I., Chen, Y., Zhang, G., Tsai, T., & Kasumov, T. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00310.2022 · Cited by 11
TC2N inhibits distant metastasis and stemness of breast cancer via blocking fatty acid synthesis
Hao, X., Lv, Y., Li, D., Bai, F., Gong, J., Pan, G., Su, L.-X., Wang, Y., Fu, W., Liu, B., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-023-04721-3 · Cited by 11
KAT8, lysine acetyltransferase 8, is required for adipocyte differentiation in vitro
Burrell, J. A., & Stephens, J. M. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166103 · Cited by 11
Oczkowicz, M., Szmatoła, T., Świątkiewicz, M., Pawlina‐Tyszko, K., Gurgul, A., & Ząbek, T. (2018) · BMC Genomics · doi:10.1186/s12864-018-5265-x · Cited by 11
Zhang, M., Bai, J., Yuan, H., Duan, X., Yu, L., Li, Y., Li, K., Rile, S., Wang, X., Wang, H., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07404-7 · Cited by 10
Liu, X., Liang, Z., Duan, H., Yu, J., Qin, Z., Li, J., Li, Z., Wu, Q., Xiao, W., Shen, C., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166472 · Cited by 10
USP14 Regulates Cancer Cell Growth in a Fatty Acid Synthase-Independent Manner
Yang, J. S., Yoon, N., Kong, M., Jung, B. H., Lee, H., & Park, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413437 · Cited by 10
Luo, Q., Wang, Q., Shi, J., Lv, Q., Dong, Z., Li, W., Xia, Y., Liu, J., & Yang, H. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07782-y · Cited by 10
Emerging roles of TRIM in metabolic regulation
Wang, J., Wang, Q., Li, X., Cai, Q., Bi, Y., Xu, C., Bai, H., Gu, L., Chang, G., & Chen, S. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156394 · Cited by 11
Deng, Z., Liu, L., Xie, G., Zheng, Z., Li, J., Tan, W., Deng, Y., Zhang, J., Liang, M., Wu, Y., et al. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100721 · Cited by 10
BF175 inhibits endometrial carcinoma through SREBP-regulated metabolic pathways in vitro
Wang, Q., Hu, R., Li, W., Tai, Y., Gu, W., Das, B. C., Yang, F., Ji, J., Wang, C., & Zhou, J. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111135 · Cited by 9
Wu, S., Huang, C., Chen, Y.-R., Huang, H., Huang, W., & Lai, Y. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104857 · Cited by 11
L’acide gras synthase, une enzyme « multi-FASette »
Raab, S., & Lefebvre, T. (2022) · médecine/sciences · doi:10.1051/medsci/2022062 · Cited by 9
Guo, X., Li, D., Song, J., Yang, Q., Wang, M., Yang, Y., Wang, L., Hou, X., Chen, L., & Li, X. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154290 · Cited by 9
Yang, T., Luo, Y., Liu, J., Liu, F., Ma, Z., Liu, G., Li, H., Wen, J., Chen, C., & Zeng, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1182434 · Cited by 8
Zhang, F., Lv, T., Xu, T., Li, J., Lian, J., Lin, S., Hu, Q., Jin, Y., Feng, J., & Zhang, X. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103978 · Cited by 8
Approaches to Measuring the Activity of Major Lipolytic and Lipogenic Enzymes In Vitro and Ex Vivo
Wilhelm, M., Rossmeislová, L., & Šiklová, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911093 · Cited by 6
Neglected PTM in animal adipogenesis: E3-mediated ubiquitination
Ran, H., Li, C., Zhang, M., Zhong, J., & Wang, H. (2023) · Gene · doi:10.1016/j.gene.2023.147574 · Cited by 6
da Silveira, M. B., Pansa, C. C., Malaspina, O., & Moraes, K. C. M. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06364-3 · Cited by 5
Geng, Y., Luo, H., & Gao, F. (2025) · BMC Biology · doi:10.1186/s12915-025-02418-1 · Cited by 4
[Lipid Metabolic Reprogramming and Metabolic Stress in Liver Cancer].
Xu, Z. Y., & Yuan, K. (2021) · 四川大学学报:医学版 · doi:10.12182/20210760506 · Cited by 4
Chan, K. K., Au, K. K., Suen, L.-H., Leung, B., Wong, C., Leow, W. Q., Lim, T. K. H., Ng, I. O., Chung, C. Y., & Lo, R. C. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.08.005 · Cited by 4
Balboni, N., Babini, G., Poeta, E., Protti, M., Mercolini, L., Magnifico, M. C., Barile, S. N., Massenzio, F., Pignataro, A., Giorgi, F. M., et al. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00563-z · Cited by 4
Wang, J., Luo, Y., Limbu, S. M., Qian, Y., Zhang, Y., Li, R., Zhou, W.-H., Qiao, F., Chen, L., Zhang, M., et al. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109678 · Cited by 4
Metadata
- Authors
- Lin, H.-P., Cheng, Z.-L., He, R.-Y., Song, L., Tian, M.-X., Zhou, L.-S., Groh, B. S., Liu, W.-R., Ji, M.-B., Ding, C., Shi, Y.-H., Guan, K.-L., Ye, D., & Xiong, Y.
- Affiliations
- Shanghai Medical College of Fudan University (CN)
- 4State Key Laboratory of Surface Physics and Department of Physics, Fudan University, Shanghai, China.
- Beijing Proteome Research Center (CN)
- Fudan University (CN)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Guan, Kun-Liang
- Ye, Dan
- Xiong, Yue
- ORCID
- Venue
- Cancer Research
- Published
- 2016-11-30
- Volume
- 76
- Issue
- 23
- Pages
- 6924-6936
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC5135623
- OpenAlex
- W2530450137
- Cited by
- 150
- References
- 51
- Citations by year
- 2026: 16 · 2025: 18 · 2024: 27 · 2023: 26 · 2022: 13 · 2021: 16 · 2020: 19 · 2019: 5 · 2018: 7 · 2017: 3
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- MOST 973 Program (2012CB910303 and 2012CB910101)
- NSFC (81372198 and 81522033, 81120108016)
- Shanghai Committee of Science and Technology, China (14QA1400600 and 16JC1404000)
- NIH (GM067113 and CA063834, CA196878 and GM51586)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Keywords
- fatty acid synthase, KAT8, HDAC3, protein acetylation, protein deacetylation, ubiquitin-proteasome degradation, TRIM21, E3 ubiquitin ligase, de novo lipogenesis, tumor cell proliferation, hepatocellular carcinoma, cancer therapy targets
- MeSH terms
- Acetylation, Humans, Signal Transduction, Cell Growth Processes, Cell Proliferation, Lipogenesis, Tumor Microenvironment, Fatty Acid Synthases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review